187 related articles for article (PubMed ID: 33130965)
21. Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer.
Tang Y; Zhao Y; Song X; Song X; Niu L; Xie L
J Clin Lab Anal; 2019 Nov; 33(9):e23004. PubMed ID: 31420913
[TBL] [Abstract][Full Text] [Related]
22. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.
Li Z; Yao H; Wang S; Li G; Gu X
J Exp Clin Cancer Res; 2020 Aug; 39(1):160. PubMed ID: 32799891
[TBL] [Abstract][Full Text] [Related]
23. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
24. miR-455 Functions as a Tumor Suppressor Through Targeting GATA6 in Colorectal Cancer.
Yunqi H; Fangrui Y; Yongyan Y; Yunjian J; Wenhui Z; Kun C; Min L; Xianfeng L; Caixia B
Oncol Res; 2019 Feb; 27(3):311-316. PubMed ID: 29615149
[TBL] [Abstract][Full Text] [Related]
25. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
26. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
27. The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer.
Liu Y; Chen X; Cheng R; Yang F; Yu M; Wang C; Cui S; Hong Y; Liang H; Liu M; Zhao C; Ding M; Sun W; Liu Z; Sun F; Zhang C; Zhou Z; Jiang X; Chen X
Mol Cancer; 2018 Jan; 17(1):11. PubMed ID: 29351796
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
Huang Y; Xiao W; Jiang X; Li H
Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Value Investigation and Bioinformatics Analysis of miR-31 in Patients with Lymph Node Metastasis of Colorectal Cancer.
Zhang WW; Ming XL; Rong Y; Huang CQ; Weng H; Chen H; Bian JM; Wang FB
Anal Cell Pathol (Amst); 2019; 2019():9740475. PubMed ID: 31934534
[TBL] [Abstract][Full Text] [Related]
30. Ten-eleven translocation 1 (TET1) gene is a potential target of miR-21-5p in human colorectal cancer.
Cheng YW; Chou CJ; Yang PM
Surg Oncol; 2018 Mar; 27(1):76-81. PubMed ID: 29549908
[TBL] [Abstract][Full Text] [Related]
31. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.
Tokarz P; Blasiak J
Acta Biochim Pol; 2012; 59(4):467-74. PubMed ID: 23173124
[TBL] [Abstract][Full Text] [Related]
32. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
Yan L; Yao J; Qiu J
Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
[TBL] [Abstract][Full Text] [Related]
33. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs as potential therapeutic targets to predict responses to oxaliplatin in colorectal cancer: From basic evidence to therapeutic implication.
Moradi Marjaneh R; Khazaei M; Ferns GA; Avan A; Aghaee-Bakhtiari SH
IUBMB Life; 2019 Oct; 71(10):1428-1441. PubMed ID: 31322820
[TBL] [Abstract][Full Text] [Related]
35. C8orf48 inhibits the tumorigenesis of colorectal cancer by regulating the MAPK signaling pathway.
Lei L; An G; Zhu Z; Liu S; Fu Y; Zeng X; Cao Q; Yan B
Life Sci; 2021 Feb; 266():118872. PubMed ID: 33309715
[TBL] [Abstract][Full Text] [Related]
36. MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study.
Chen E; Li Q; Wang H; Yang F; Min L; Yang J
Biomed Pharmacother; 2018 Oct; 106():1370-1377. PubMed ID: 30119209
[TBL] [Abstract][Full Text] [Related]
37. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer.
Wang ZS; Zhong M; Bian YH; Mu YF; Qin SL; Yu MH; Qin J
Oncotarget; 2016 Jul; 7(28):44266-44276. PubMed ID: 27329595
[TBL] [Abstract][Full Text] [Related]
39. Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network.
Zhu Y; Peng Q; Lin Y; Zou L; Shen P; Chen F; Min M; Shen L; Chen J; Shen B
Oncotarget; 2017 Jan; 8(2):2233-2248. PubMed ID: 27903980
[TBL] [Abstract][Full Text] [Related]
40. The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer.
Zhao L; Yu H; Yi S; Peng X; Su P; Xiao Z; Liu R; Tang A; Li X; Liu F; Shen S
Oncotarget; 2016 Jul; 7(29):45370-45384. PubMed ID: 27248318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
